Dr. Michael Blue, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 501 E Locust St, Lone Pine, CA 93545 Phone: 760-876-5501 |
News Archive
Angiosarcoma Project, a patient-partnered genomics study, identified immune checkpoint inhibition as a potential treatment option for patients with angiosarcomas of the head, face, neck, or scalp, according to data presented at the fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference.
Noscira, a Grupo Zeltia subsidiary specialized in research and development of drugs to treat neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to its neuroprotector drug Tideglusib (ZentylorTM) to treat Progressive Supranuclear Palsy (PSP), a fast-advancing fatal degenerative brain disorder.
A report published in The New England Journal of Medicine provides confirmation of what researchers say is the first case of HIV remission in a child born with the virus.
Integrating artificial intelligence to analyze imaging data allows early recognition of heart disease, saving patients' time, money and, most importantly, lives.
The Mount Sinai Hospital, Mount Sinai West, Mount Sinai St. Luke's, Mount Sinai Queens, Mount Sinai Beth Israel, and New York Eye and Ear Infirmary of Mount Sinai have again earned recognition as "Leaders in LGBTQ Healthcare Equality" in the Healthcare Equality Index, an annual survey by the Human Rights Campaign that encourages equal care for LGBTQ patients and recognizes health care institutions for inclusive policies and practices.
› Verified 7 days ago